Sanara Ventures To Invest $26.5M In Israeli Health Tech

July 5, 2015 | Teva Pharmaceutical Industries and Philips Healthcare will reportedly invest up to $26.5 million in Israeli medical device and health innovation startups over the next eight years through their joint fund, Sanara Ventures. Sanara Ventures has already invested in two Israeli companies, Kaleidoscope Medical, which has developed a system to shield against X-ray radiation during catherterisation procedures, as well as MGD, which creates a portable device to measure lung function in patients with Chronic Obstructive Pulmonary Disease (COPD). Sanara Ventures was established this year and is headed by its Chief Executive Assaf Barnea.